Aktis Oncology, Inc.
corporate_fare Company Profile
Aktis Oncology, Inc. (NASDAQ:AKTS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for AKTS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Aktis Oncology Adopts Restrictive Governance Post-IPO
- Aktis Oncology Completes Initial Public Offering, Raising $291M to Fund Radiopharmaceutical Pipeline
- Aktis Oncology Files for IPO to Raise Up to $316.4M to Advance Radiopharmaceutical Pipeline
- Aktis Oncology Files S-1/A for Initial Public Offering to Raise Up to $209.6M for Radiopharmaceutical Pipeline
show_chartPrice Chart
Loading chart...
feed AKTS - Filings & News (Page 2)
AKTS
Jan 12, 2026, 4:03 PM EST
Price at Filing:
$21.76
Real-time Price:
$16.46
Change:
-$5.30 (-24%)
Market Cap:
$898.255M
AKTS
Jan 09, 2026, 5:01 PM EST
Aktis Oncology Completes Initial Public Offering, Raising $291M to Fund Radiopharmaceutical Pipeline
Price at Filing:
$22.40
Real-time Price:
$16.46
Change:
-$5.94 (-27%)
Market Cap:
$898.255M
AKTS
Jan 07, 2026, 7:19 AM EST
Price at Filing:
$0.0372
Real-time Price:
$16.46
Change:
+$16.42 (+44,147%)
Market Cap:
$898.255M
AKTS
Jan 05, 2026, 6:32 AM EST
Price at Filing:
$0.0372
Real-time Price:
$16.46
Change:
+$16.42 (+44,147%)
Market Cap:
$898.255M